Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3 Pt 1
pubmed:dateCreated
1993-4-29
pubmed:abstractText
We assessed the effects of cultured human promyelocytic leukemia (HL-60) cells and polymorphonuclear leukocytes (neutrophils) isolated from peripheral human blood on tracheal smooth muscle responsiveness in 40 male Hartley guinea pigs. Undifferentiated HL-60 cells (16-25 passages) were activated in vitro by incubation with 1 microM f-Met-Leu-Phe (fMLP), and force of contraction was measured isometrically using an in situ preparation of tracheal smooth muscle. Increasing concentrations of acetylcholine (ACh; 10(-10) to 10(-6) mol/cm2 tracheal surface) were applied topically to the epithelial surface pretreated with 4 x 10(6) fMLP-activated HL-60 cells, 4 x 10(6) fMLP-activated neutrophils, 4 x 10(6) sham-activated HL-60 cells, fMLP+vehicle, or vehicle control. Topical application of fMLP-activated HL-60 cells caused a maximum active tension (AT) of 1.13 +/- 0.2 g/cm after 5 min; fMLP-activated neutrophils, sham-activated HL-60 cells, or fMLP+vehicle had no effect. The fMLP-activated HL-60 cells also caused substantial augmentation of tracheal contraction to ACh (P < 0.05 vs. sham-activated cells for all concentrations > 10(-9) mol/cm2). Although fMLP treatment caused 247 +/- 28% increase from baseline level in O2-. production, neither direct contraction nor augmentation of muscarinic stimulation was demonstrated after topical application of 4 x 10(6) neutrophils. In 12 other preparations, fMLP-activated HL-60 cells were pretreated with either 10 microM indomethacin (Indo) or 100 microM A63162, a 5-lipoxygenase inhibitor. Pretreatment with Indo caused complete blockade of direct tracheal contraction and 88 +/- 13% blockade of muscarinic augmentation; there was no effect after A63162.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0002-9513
pubmed:author
pubmed:issnType
Print
pubmed:volume
264
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
L222-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:8460711-Acetamides, pubmed-meshheading:8460711-Acetylcholine, pubmed-meshheading:8460711-Animals, pubmed-meshheading:8460711-Bronchoconstriction, pubmed-meshheading:8460711-Cell Communication, pubmed-meshheading:8460711-Cell Survival, pubmed-meshheading:8460711-Guinea Pigs, pubmed-meshheading:8460711-Humans, pubmed-meshheading:8460711-Immunohistochemistry, pubmed-meshheading:8460711-Indomethacin, pubmed-meshheading:8460711-Leukemia, Myeloid, pubmed-meshheading:8460711-Lipoxygenase, pubmed-meshheading:8460711-Lipoxygenase Inhibitors, pubmed-meshheading:8460711-Male, pubmed-meshheading:8460711-Muscle, Smooth, pubmed-meshheading:8460711-N-Formylmethionine Leucyl-Phenylalanine, pubmed-meshheading:8460711-Neutrophils, pubmed-meshheading:8460711-Phenyl Ethers, pubmed-meshheading:8460711-Prostaglandin-Endoperoxide Synthases, pubmed-meshheading:8460711-Trachea, pubmed-meshheading:8460711-Tumor Cells, Cultured
pubmed:year
1993
pubmed:articleTitle
Activation of tracheal smooth muscle responsiveness by fMLP-treated HL-60 cells and neutrophils.
pubmed:affiliation
Department of Medicine, University of Chicago, Illinois 60637.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't